Risk factors for arterial thrombosis in antiphospholipid syndrome

Thrombosis Research

Volumn 133, Issue 2, 2014, Pages 173-176

  Matyja Bednarczyk, Aleksandra ^a   Swadźba, Jakub ^a   Iwaniec, Teresa ^a   Sanak, Marek ^a   Dziedzina, Sylwia ^a   Ćmiel, Adam ^b   Musiał, Jacek ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b AGH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Poland)

Author keywords

Antiphospholipid antibodies; Antiphospholipid syndrome; Arterial thrombosis; Livedo reticularis; Polymorphisms of the platelet integrins; Risk factors for cardiovascular diseases

Indexed keywords

CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; PHOSPHOLIPID ANTIBODY; VERY LATE ACTIVATION ANTIGEN 2;

ADULT; AGED; ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; ARTICLE; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; FEMALE; GENETIC POLYMORPHISM; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LIVEDO RETICULARIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; STROKE PATIENT;

ACL; ANTICARDIOLIPIN; ANTIPHOSPHOLIPID ANTIBODIES; ANTIPHOSPHOLIPID SYNDROME; APA; APS; ARTERIAL THROMBOSIS; AT; CENTRAL NERVOUS SYSTEM; CNS; DEEP VEIN THROMBOSIS; DVT; LIVEDO RETICULARIS; LR; POLYMORPHISMS OF THE PLATELET INTEGRINS; RAYNAUD'S PHENOMENON; RISK FACTORS FOR CARDIOVASCULAR DISEASES; RP; SAPS; SECONDARY ANTIPHOSPHOLIPID SYNDROME, PAPS, PRIMARY ANTIPHOSPHOLIPID SYNDROME; SLE; SYSTEMIC LUPUS ERYTHEMATOSUS, LA, LUPUS ANTICOAGULANT, DNA, DEOXYRIBONUCLEIC ACID;

ADULT; AGED; ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; INTEGRIN ALPHA2BETA1; MALE; MIDDLE AGED; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; RETROSPECTIVE STUDIES; RISK FACTORS; THROMBOSIS; YOUNG ADULT;

EID: 84892372616     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2013.11.012     Document Type: Article

References (39)

1. A. Ruffatti, T. Del Ross, M. Ciprian, M. Nuzzo, M. Rampudda, and M.T. Bertero et al. Risk factors for a first thrombotic event in antiphospholipid antibody carriers. A multicentre, retrospective follow-up study Ann Rheum Dis 68 2009 397 399
2. P.G. De Groot, and R.H. Derksen Pathophysiology of the antiphospholipid syndrome J Thromb Haemost 3 2005 1854 1860
3. R. Cervera, J.C. Piette, J. Font, M.A. Khamashta, Y. Shoenfeld, and M.T. Camps et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients Arthritis Rheum 46 2002 1019 1027
4. R.L. Brey, E. Muscal, and J. Chapman Antiphospholipid antibodies and the brain: a consensus report Lupus 20 2011 153 157
5. E.P. Grika, P.D. Ziakas, E. Zintzaras, H.M. Moutsopoulos, and P.G. Vlachoyiannopoulos Morbidity, mortality, and organ damage in patients with antiphospholid syndrome J Rheumatol 39 2012 516 523
6. C. Antoniades, D. Tousoulis, C. Vasiliadou, E. Stefanadi, K. Marinou, and C. Stefanadis Genetic polymorphisms of platelet glycoprotein Ia and the risk for premature myocardial infarction: effects on the release of sCD40L during the acute phase of premature myocardial infarction J Am Coll Cardiol 47 2006 May 16 1959 1966
7. F. Lanni, G. Santulli, R. Izzo, S. Rubattu, B. Zanda, and M. Volpe et al. The Pl(A1/A2) polymorphism of glycoprotein IIIa and cerebrovascular events in hypertension: increased risk of ischemic stroke in high-risk patients J Hypertens 25 2007 Mar 551 556
8. B. Nieswandt, I. Pleines, and M. Bender Platelet adhesion and activation mechanisms in arterial thrombosis and ischaemic stroke J Thromb Haemost 9 Suppl. 1 2011 Jul 92 104
9. S. Jiménez, D. Tàssies, G. Espinosa, A. García-Criado, J. Plaza, and J. Monteagudo et al. Double heterozygosity polymorphisms for platelet glycoproteins Ia/IIa and IIb/IIIa increases arterial thrombosis and arteriosclerosis in patients with the antiphospholipid syndrome or with systemic lupus erythematosus Ann Rheum Dis 67 2008 Jun 835 840
10. Miyakis S. Lockshin MD, T. Atsumi, D.W. Branch, R.L. Brey, and R. Cervera et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) J Thromb Haemost 4 2006 295 306
11. V. Pengo, A. Tripodi, G. Reber, J.H. Rand, T.L. Ortel, and M. Galli et al. Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis J Thromb Haemost 7 2009 1737 1740
12. J. Swadzba, T. Iwaniec, M. Pulka, B. De Laat, P.G. De Groot, and J. Musial Lupus anticoagulant: performance of the tests as recommended by the latest ISTH guidelines J Thromb Haemost 9 2011 1776 1783
13. E.N. Harris, A.E. Gharavi, S.P. Patel, and G.R. Hughes Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986 Clin Exp Immunol 68 1987 215 222
14. J. Swadźba, L.S. de Clerck, W.J. Stevens, C.H. Bridts, K.A. van Cotthem, and J. Musiał et al. Anticardiolipin, anti-β2glycoprotein- 1, anti-prothrombin antibodies and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis J Rheumatol 24 1997 1710 1715
15. G. Lakos, E.J. Favaloro, E.N. Harris, P.L. Meroni, A. Tincani, and R.C. Wong et al. International Consensus Guidelines on Anticardiolipin and Anti-β2-Glycoprotein I Testing Arthritis Rheum 64 2012 1 10
16. J. Swadźba, M. Sanak, T. Iwaniec, S. Dziedzina, and J. Musiał Valine/Leucine 247 polymorphism of β2GPI in patients with antiphospholipid syndrome: lack of association with anti - β2GPI antibodies Lupus 15 2006 218 222
17. T. Hastie, R. Tibshirani, and J. Friedmann The Elements of Statistical Learning 2001 Springer
18. R. Cervera, M.C. Boffa, M.A. Khamashta, and G.R. Hughes The Euro-Phospholipid project: epidemiology of the antiphospholipid syndrome in Europe Lupus 18 2009 889 893
19. C. Francès, S. Niang, E. Laffitte, F. Pelletier, N. Costedoat, and J.C. Piette Dermatologic manifestations of the antiphospholipid syndrome: two hundred consecutive cases Arthritis Rheum 52 2005 1785 1793
20. V. Janardhan, P.A. Wolf, and C.S. Kase et al. Anticardiolipin antibodies and risk of ischemic stroke and transient ischemic attack. The Framingham Cohort and Offspring Study Stroke 35 2004 736
21. R. Cervera, M.A. Khamashta, and Y. Shoenfeld et al. Euro-Phospholipid Project Group (European Forum on Antiphospholipid Antibodies. Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients Ann Rheum Dis 68 2009 1428 1432
22. M. Turiel, P. Sarzi-Puttini, and R. Peretti, E. Rossi, F. Atzeni, W. Parsons et al. Thrombotic risk factors in primary antiphospholipid syndrome: a 5-year prospective study Stroke 36 2005 1490 1494
23. A. Ruffatti, T. Del Ross, M. Ciprian, M.T. Bertero, S. Sciascia, and S. Scarpato et al. Risk factors for a first thrombotic event in antiphospholipid antibody carriers: a prospective multicentre follow-up study Ann Rheum Dis 2011 1083 1086
24. J. Swadźba, T. Iwaniec, A. Szczeklik, and J. Musiał Revised classification criteria for antiphospholipid syndrome and the thrombotic risk in patients with autoimmune diseases J Thromb Haemost 5 2007 1883 1899
25. A. Danowski, T.S. Kickler, and M. Petri Anti-ß2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus J Rheumatol 33 2006 1775 1779
26. M. Galli, D. Luciani, G. Bertolini, and T. Barbui Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature Blood 101 2003 1827 1832
27. A. Martinez-Berriotxoa, G. Ruiz-Irastorza, M.V. Egurbide, M. Garmendia, J. Gabriel Erdozain, and I. Villar et al. Transiently positive anticardiolipin antibodies and risk of thrombosis in patients with systemic lupus erythematosus Lupus 16 2007 810 816
28. M. Galli, D. Luciani, G. Bertolini, and T. Barbui Anti-beta 2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome Blood 102 2003 2717 2723
29. A. Danowski, M.N. de Azevedo, J.A. de Souza Papi, and M. Petri Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus J Rheumatol 36 2009 1195 1199
30. R.T. Urbanus, B. Siegerink, M. Roest, F.R. Rosendaal, P.G. de Groot, and A. Algra Aniphospholipid antibodies and risk of myocardial infarction and ischemic stroke in young women in the RATIO study: a case -control study Lancet Neurol 8 2009 998 1005
31. P.L. Meroni, F. Peyvandi, L. Foco, L. Bernardinelli, R. Fetiveau, and P.M. Mannucci et al. Anti-beta 2 glycoprotein I antibodies and the risk of myocardial infarction in young premenopausal women J Thromb Haemost 5 2007 2421 2428
32. R.L. Brey, R.D. Abbott, J.D. Curb, D.S. Sharp, G.W. Ross, and C.L. Stallworth et al. beta(2)-Glycoprotein 1-dependent anticardiolipin antibodies and risk of ischemic stroke and myocardial infarction: the Honolulu Heart Program Stroke 32 2001 1701 1706
33. V. Pengo, A. Ruffatti, C. Legnani, S. Testa, T. Fierro, and F. Marongiu et al. Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study Blood 118 2011 4714 4718
34. M.G. Tektonidou, K. Laskari, D.B. Panagiotakos, and H.M. Moutsopoulos Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies Arthritis Rheum 61 2009 29 36
35. D. Erkan, Y. Yazici, M.G. Peterson, L. Sammaritano, and M.D. Lockshin A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome Rheumatology (Oxford) 41 2002 924 929
36. [M. Govoni, S. Bombardieri, A. Bortoluzzi, L. Caniatti, C. Casu, and F. Conti et al. Factors and comorbidities associated with first neuropsychiatric event in systemic lupus erythematosus: does a risk profile exist? A large multicentre retrospective cross-sectional study on 959 Italian patients Rheumatology (Oxford) 51 2012 157 168
37. M. Petri Thrombosis and systemic lupus erythematosus: the Hopkins Lupus Cohort perspective Scand J Rheumatol 25 1996 191 193
38. P. Verro, S.R. Levine, and G.E. Tietjen Cerebrovascular Ischemic Events With High Positive Anticardiolipin Antibodies Stroke 29 1998 2245 2253
39. K.E. Hansen, D.F. Kong, K.D. Moore, and T.L. Ortel Risk factors associated with thrombosis in patients with antiphospholipid antibodies J Rheumatol 28 2001 2018 2024